Published in
Public Library of Science, PLoS ONE, 8(12), p. e0182852, 2017
DOI: 10.1371/journal.pone.0182852
Links
Tools
The selective PI3Kα inhibitor BYL719 as a novel therapeutic option for neuroendocrine tumors: Results from multiple cell line models.
Journal article published in 2017 by
Svenja Nölting,
Jakob Rentsch,
Helma Freitag 
,
Katharina Detjen,
Markus Möbs ,
Victoria Weissmann,
Britta Siegmund,
Christoph J. Auernhammer,
Franziska Briest ,
Elke Tatjana Aristizabal Prada,
Auernhammer Cj,
Aristizabal Prada Et,
Michael Lauseker,
Ashley Grossman,
Samantha Exner
and other authors.
,
Katharina Detjen,
Markus Möbs ,
Victoria Weissmann,
Britta Siegmund,
Christoph J. Auernhammer,
Franziska Briest ,
Elke Tatjana Aristizabal Prada,
Auernhammer Cj,
Aristizabal Prada Et,
Michael Lauseker,
Ashley Grossman,
Samantha Exner
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Data provided by 